BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34931516)

  • 1. Targeted Covalent Inhibition of Small CTD Phosphatase 1 to Promote the Degradation of the REST Transcription Factor in Human Cells.
    Medellin B; Yang W; Konduri S; Dong J; Irani S; Wu H; Matthews WL; Zhang ZY; Siegel D; Zhang Y
    J Med Chem; 2022 Jan; 65(1):507-519. PubMed ID: 34931516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase activity of small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST).
    Burkholder NT; Mayfield JE; Yu X; Irani S; Arce DK; Jiang F; Matthews WL; Xue Y; Zhang YJ
    J Biol Chem; 2018 Oct; 293(43):16851-16861. PubMed ID: 30217818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells.
    Panina SB; Schweer JV; Zhang Q; Raina G; Hardtke HA; Kim S; Yang W; Siegel D; Zhang YJ
    BMC Biol; 2024 Apr; 22(1):83. PubMed ID: 38609948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inactivation of a human neuronal silencing phosphatase by a small molecule inhibitor.
    Zhang M; Cho EJ; Burstein G; Siegel D; Zhang Y
    ACS Chem Biol; 2011 May; 6(5):511-9. PubMed ID: 21348431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
    Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
    Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.
    Charbord J; Poydenot P; Bonnefond C; Feyeux M; Casagrande F; Brinon B; Francelle L; Aurégan G; Guillermier M; Cailleret M; Viegas P; Nicoleau C; Martinat C; Brouillet E; Cattaneo E; Peschanski M; Lechuga M; Perrier AL
    Stem Cells; 2013 Sep; 31(9):1816-28. PubMed ID: 23712629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
    McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
    Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small CTD phosphatases function in silencing neuronal gene expression.
    Yeo M; Lee SK; Lee B; Ruiz EC; Pfaff SL; Gill GN
    Science; 2005 Jan; 307(5709):596-600. PubMed ID: 15681389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of substrate specificity for a CTD phosphatase, SCP1, by proteomic screening of binding partners.
    Kim YJ; Bahk YY
    Biochem Biophys Res Commun; 2014 May; 448(2):189-94. PubMed ID: 24769477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development.
    Visvanathan J; Lee S; Lee B; Lee JW; Lee SK
    Genes Dev; 2007 Apr; 21(7):744-9. PubMed ID: 17403776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 26b encoded by the intron of small CTD phosphatase (SCP) 1 has an antagonistic effect on its host gene.
    Sowa N; Horie T; Kuwabara Y; Baba O; Watanabe S; Nishi H; Kinoshita M; Takanabe-Mori R; Wada H; Shimatsu A; Hasegawa K; Kimura T; Ono K
    J Cell Biochem; 2012 Nov; 113(11):3455-65. PubMed ID: 22678827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squelching glioblastoma stem cells by targeting REST for proteasomal degradation.
    Zhang P; Lathia JD; Flavahan WA; Rich JN; Mattson MP
    Trends Neurosci; 2009 Nov; 32(11):559-65. PubMed ID: 19748686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
    Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
    Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation.
    Hueng DY; Hsieh CH; Cheng YC; Tsai WC; Chen Y
    J Nutr Biochem; 2017 Mar; 41():109-116. PubMed ID: 28068557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal domain small phosphatase 1 and MAP kinase reciprocally control REST stability and neuronal differentiation.
    Nesti E; Corson GM; McCleskey M; Oyer JA; Mandel G
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):E3929-36. PubMed ID: 25197063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
    McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
    Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
    ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction.
    Gilmartin AG; Faitg TH; Richter M; Groy A; Seefeld MA; Darcy MG; Peng X; Federowicz K; Yang J; Zhang SY; Minthorn E; Jaworski JP; Schaber M; Martens S; McNulty DE; Sinnamon RH; Zhang H; Kirkpatrick RB; Nevins N; Cui G; Pietrak B; Diaz E; Jones A; Brandt M; Schwartz B; Heerding DA; Kumar R
    Nat Chem Biol; 2014 Mar; 10(3):181-7. PubMed ID: 24390428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
    Zech SG; Kohlmann A; Zhou T; Li F; Squillace RM; Parillon LE; Greenfield MT; Miller DP; Qi J; Thomas RM; Wang Y; Xu Y; Miret JJ; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2016 Jan; 59(2):671-86. PubMed ID: 26700752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type-specific regulation of RE-1 silencing transcription factor (REST) target genes.
    Hohl M; Thiel G
    Eur J Neurosci; 2005 Nov; 22(9):2216-30. PubMed ID: 16262660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.